An overview of chemical drug for oncology application & approvals in China betwween 2005-2010

Chinese Pharmaceutical Journal

Volumn 45, Issue 22, 2010, Pages 1781-1785

  Chen, Xiao Yuan ^a   Zhang, Ning ^a   Peng, Jian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CHINA; DRUG APPROVAL; ONCOLOGY; SHORT SURVEY;

EID: 78651252803     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. SFDA. Drag Registration Regulation[S]. 2007.
2. STEGMEIER F, WARMUTH M, SELLERS W R, et al. Targeted cancer therapies in the twenty-first century: lessons from imatinib [J]. Clin Pharmacol Ther, 2010,87(5):543-552.
3. FDA. Guidance for Industry Fast Track Drug Development Programs-Designation, Development, and Application Review. 2006.
4. EMEA. Guideline on Procedures for the Granting of a Marketing Authorization Under Exceptional Circumstances[S]. 2005.